Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms

Katarina Kopčalić, Ivana Z. Matić, Irina Besu, Vesna Stanković, Zoran Bukumirić, Tatjana P. Stanojković, Aleksandar Stepanović, Marina Nikitović

Open source

DOI
10.1186/s12885-022-10255-6
Published
2022-11-11
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-022-10255-6,
  title = {Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms},
  author = {Katarina Kopčalić and Ivana Z. Matić and Irina Besu and Vesna Stanković and Zoran Bukumirić and Tatjana P. Stanojković and Aleksandar Stepanović and Marina Nikitović},
  year = {2022},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-022-10255-6},
  url = {https://doi.org/10.1186/s12885-022-10255-6}
}

RIS

TY  - JOUR
TI  - Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms
AU  - Katarina Kopčalić
AU  - Ivana Z. Matić
AU  - Irina Besu
AU  - Vesna Stanković
AU  - Zoran Bukumirić
AU  - Tatjana P. Stanojković
AU  - Aleksandar Stepanović
AU  - Marina Nikitović
PY  - 2022
JO  - BMC Cancer
DO  - 10.1186/s12885-022-10255-6
UR  - https://doi.org/10.1186/s12885-022-10255-6
ER  - 

APA

Kopčalić, K., Matić, I. Z., Besu, I., Stanković, V., Bukumirić, Z., Stanojković, T. P., Stepanović, A., & Nikitović, M. (2022). Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms. BMC Cancer. https://doi.org/10.1186/s12885-022-10255-6

Source records